Autologous Tenocytes Therapy to Improve the Healing Process of Tennis Elbow – A Preliminary Clinical Trail
Autologous Tenocytes Therapy to Improve the Healing Process of Tennis Elbow
Orthocell Pty Ltd
30 participants
Aug 15, 2007
Interventional
Conditions
Summary
The aim of this study is to assess the potential role of autologous tenocytes therapy in the healing process of tennis elbow.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Autologous Tenocytes Injection Autologous tenocytes will be digested from a small epitendineum tissue (connective tissue on the surface of tendon) harvested from patients’ patellar tendon. After a period of in vivo cultivation, 2ml of autologous tenocytes at concentration of 3X106cell/ml will be inject into the elbow site where feel most pain.Patients will be rescheduled for follow-up appointment at 4 and 12 weeks after the injection. During any stage of this study, patients are obligation free to leave the experiment. Those chosen to leave will be referral to standard treatment.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12607000402448